Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Novo Nordisk Pharma GmbH v S (C-310/13)
Judgment
Consideration of the question referred
28

Novo Nordisk Pharma GmbH v S (C-310/13)

Judgment of 20 Nov 2014law://eu/cjeu/2013/c-310-13/para_28@2026-11-11

28However, such national legislation does not bring about a reversal of the burden of proof, which is for the victim to discharge, and does not introduce any change in the circumstances, listed in Article 7 of Directive 85/374, in which the manufacturer is to be exempt from liability.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice · Fourth Chamber
Case: C-310/13 · ECLI:EU:C:2014:2385
Decided: 20 Nov 2014
Procedure: Preliminary reference · referred by the Bundesgerichtshof (Germany)
Applicant: Novo Nordisk Pharma GmbH
Defendant: S.
Rapporteur: M. Safjan
Advocate General: M. Szpunar
Bench: 5 judges
L. Bay Larsen, J. Malenovský, M. Safjan, A. Prechal, K. Jürimäe
Language: German
Official: CURIA · EUR-Lex 62013CJ0310

Topics

Consumer protection Pharmaceutical and cosmetic products

History · 1 version

20 Nov 2014Reading

Connections

Interprets 1: Council Directive 85/374/EEC of 25 July 1985 on the approximation of the laws, regulations and administrative provisions of the Member States concerning liability for defective products
Cited by 2: N. W and Others v Sanofi Pasteur MSD SNC and Others (C-621/15); Sogefinancement SAS v RW and UV (C-50/22)2 provisions
Cites 3: Council Directive 85/374/EEC of 25 July 1985 on the approximation of the laws, regulations and administrative provisions of the Member States concerning liability for defective products; Centre hospitalier universitaire de Besançon v Thomas Dutrueux and Caisse primaire d'assurance maladie du Jura (C-495/10); Novo Nordisk Pharma GmbH v S (C-310/13)